Canada Fires Back At Trump: Up to 50% Tariffs on $20 Billion of US Goods
Canada hit back at Trump with tariffs of up to 50% on $20B of U.S. goods, escalating the trade war ahead of Sept. 8.
Stocks · News reference
Earnings Scheduled For July 16, 2026
Companies Reporting Before The Bell • U.S. Bancorp (NYSE:USB) is likely to report quarterly earnings at $1.27 per share on revenue of $7.59 billion. • New Horizon Aircraft (NASDAQ:HOVR) is expected to report earnings
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Alcoa Breaks Ground For Its Gallium Production Plant Co-Located At The Wagerup Alumina Refinery In Western Australia
Shares of aluminum-related companies are trading higher as investors expect that the U.S. and Canada will fail to reach a trade agreement ahead of Saturday's deadline. The inability to reach an agreement could expose Canada to a 50% tariff on several key exports, which may benefit U.S.-based producers.
Shares of steel and aluminum-related companies are trading lower amid expectations for progress on a U.S.-Canada trade agreement before the weekend. A trade framework may lessen investor interest in finished metals producers that would have benefitted from domestic U.S. production under continued tariffs.
Baby Food & Infant Formula Market Size to Reach USD 74.30 Billion by 2035 | Report by SNS Insider
The global Baby Food and Infant Formula Market was valued at USD 40.37 billion in 2025 and is projected to reach USD 74.30 billion by 2035, growing at a CAGR of 6.29%. Growth is driven by urbanization, increasing parental health consciousness, demand for organic/premium products, and e-commerce expansion. However, recent product recalls by major manufacturers highlight safety concerns in the industry.
Renal Denervation Market Size, Share & Trends Analysis - Global Opportunity Analysis and Industry Forecast (2026-2036)
The global renal denervation market is expected to experience significant growth driven by rising resistant hypertension cases, positive clinical trial results, regulatory approvals, and technological advances in radiofrequency, ultrasound, and micro-infusion technologies. North America currently leads the market while Asia-Pacific is projected to grow fastest. The minimally invasive procedure treats uncontrolled hypertension by disrupting sympathetic nerves surrounding renal arteries.